-

Ardent Health Files Registration Statement for Proposed Initial Public Offering

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health Partners, LLC (“Ardent Health”) today announced it has publicly filed a registration statement on Form S-1 (the “Registration Statement”) with the U.S. Securities and Exchange Commission (the “SEC”) relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Ardent Health has applied to list its common stock on the New York Stock Exchange under the ticker symbol “ARDT.”

Ardent Health intends to use the net proceeds from the proposed offering to repay certain existing indebtedness and for general corporate purposes.

J.P. Morgan, BofA Securities and Morgan Stanley will act as lead book-running managers for the proposed offering. Stephens Inc., Citigroup, Leerink Partners, RBC Capital Markets, Truist Securities, and Mizuho will also act as bookrunners for the proposed offering. Capital One Securities and Loop Capital Markets will act as co-managers for the proposed offering.

The proposed offering will be made only by means of a prospectus, which forms a part of the Registration Statement. Once available, copies of the Registration Statement and preliminary prospectus included therein relating to this proposed offering may be obtained for free by visiting EDGAR on the SEC’s website at www.sec.gov. Alternatively, copies of the prospectus, when available, may be obtained from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at 866-803-9204 or by email at prospectus-eq_fi@jpmorganchase.com; BofA Securities, NC1-022-02-25, 201 North Tryon Street, Charlotte, NC, 28255-0001, Attn: Prospectus Department, by telephone at 800-294-1322 or by email at dg.prospectus_requests@bofa.com; or Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014.

The Registration Statement relating to the proposed offering has been filed with the SEC but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the Registration Statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended.

About Ardent Health
Ardent Health is a leading provider of healthcare in growing midsize urban communities across the country. With a focus on people and investments in innovative services and technologies, Ardent Health is passionate about making healthcare better and easier to access. Through its subsidiaries, Ardent Health delivers care through a system of 30 acute care hospitals and more than 200 sites of care with over 1,700 providers across six states.

Contacts

Media Relations:
Rebecca Kirkham
Ardent Health
rebecca.kirkham@ardenthealth.com

Investor Relations:
Stefan Neely
Vallum Advisors
ARDT@val-adv.com

Ardent Health Partners, LLC


Release Versions

Contacts

Media Relations:
Rebecca Kirkham
Ardent Health
rebecca.kirkham@ardenthealth.com

Investor Relations:
Stefan Neely
Vallum Advisors
ARDT@val-adv.com

More News From Ardent Health Partners, LLC

Ardent Health Announces Fourth Quarter and Full Year 2025 Results Conference Call and Webcast Date

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it will issue its fourth quarter and full year 2025 results after the market closes on Wednesday, March 4, 2026. A conference call will be held the following day, Thursday, March 5, 2026, at 10 a.m. ET to review the Company’s financial results and conduct a question-and-answer session. A webcast of the conference call and ac...

Ardent Health Announces $50 Million Share Repurchase Program Authorization

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced its Board of Directors has authorized a share repurchase program of up to $50 million. “This authorization reflects our conviction in the fundamental strength of Ardent’s business and our ability to deliver sustained, long-term shareholder value,” said Marty Bonick, President and Chief Executive Officer. “With a strong balance sh...

Ardent Health Reports Third Quarter 2025 Results

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health, Inc. (NYSE: ARDT) ("Ardent Health" or the "Company"), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the quarter ended September 30, 2025. Third Quarter 2025 Operating and Financial Summary All comparisons are versus the same prior year period. See the footnotes to the Operating Statistics table of this press release for definitions of the metrics below and a full list of key...
Back to Newsroom